Exenatide Once Weekly Over 2 Years as a Potential Disease Modifying Treatment for Parkinson's Disease
Condition: Parkinson's Disease Intervention: Drug: Exenatide extended release 2mg subcutaneous injection (Bydureon) Sponsor: University College, London Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials